Several lines of evidence indicate that aberrations in immune-inflammatory pathways may
contribute to the pathophysiology of schizophrenia spectrum disorders. Here, we propose a …

Cardiovascular diseases (CVD) cause about 1/3 of global deaths. Therefore, new strategies
for the prevention and treatment of cardiovascular events are highly sought-after. Vitamin E …

In 2001, the first author of this paper reported that schizophrenia is associated with an
increased frequency of the haptoglobin (Hp)-2 gene. The precursor of Hp-2 is zonulin, a …

Life expectancy as a measure of population health does not reflect years of healthy life. The
average life expectancy in the Asia-Pacific region has more than doubled since 1900 and is …

Survivors of cerebral aneurysm rupture are at risk for significant morbidity and neurological
deficits. Much of this is related to the effects of blood in the subarachnoid space which …

Abstract Background Haptoglobin (Hp) functions as an antioxidant by binding with
haemoglobin. We investigated whether serum Hp has a causal effect on macroangiopathy …

This review outlines the current clinical research investigating how the haptoglobin (Hp)
genetic polymorphism and stroke occurrence are implicated in sickle cell disease (SCD) …

Urine haptoglobin (uHP) level prospectively predicts diabetic kidney disease (DKD)
progression. Here, we aim to identify genetic determinants of uHP level and evaluate …

Abstract Objective Haptoglobin (Hp) is an acute‐phase protein secreted by the liver; its
concentration increases rapidly during infection, inflammation, and tumor formation. It has …

Abstract Purpose of Review Despite improvements in treatment, people with type 1 diabetes
continue to have increased cardiovascular disease (CVD) risk. Glycemic control does not …